argyrotsipi/train-dataset huggingface dataset:
Young People’s Mental Health — House of Commons, 2016-10-27
Topic: Health
Nicola Blackwood (Conservative, Centre-right): I am happy to look at it. We are very clear that there is a vital role for the voluntary sector to play in delivering some of these services. We hope that local transformation plans will be part of the way in which this is clarified. The programme to deliver transparency and accountability will be essential if local areas are not only to design effective services that match the needs of their local populations, but to be held to account for delivering them. I will not beat about the bush. We recognise that a complex and severe set of challenges faces children and young people’s mental health services. This area has been undervalued and underfunded for far too long While I am happy to investigate funding formulas such as those mentioned by the hon. Member for Ilford North in relation to Redbridge, I agree with him that leadership and accountability are also key to making the changes that we need. That is why we are committed to delivering real changes across the whole system, not just in funding, and to building on the ambitious vision set out in "Future in mind". I pay tribute to my predecessors for the work they have done to bring those forward. As the hon. Member for Dulwich and West Norwood has said, we need to go further to drive through these changes, which young people have told us they want to see Children want to grow up to be confident and resilient, and they want to be supported to fulfil their goals and ambitions. We are placing an emphasis on building in that resilience, on promoting good mental health and wellbeing, on prevention—it is so important, as the shadow Minister has said—and on early intervention, as a number of the recommendations propose. We are looking, in particular, at how we can do more upstream to prevent mental health problems before they arise.
Young People’s Mental Health — House of Commons, 2016-10-27
Topic: Health
Nicola Blackwood (Conservative, Centre-right): I think I have already answered those questions. The Government have been clear that we think that mental health funding for children and young people, as well as for other areas of mental health, needs to increase. That is why we have increased mental health funding to local areas and we are putting in place measures to improve accountability and transparency, and the STPs, to make sure that that can be tracked locally. We are going to see how it works in the first instance.
HS2 Ltd: Communication and Engagement — House of Commons, 2016-10-27
Topic: Health
Jeremy John Elton Lefroy (Conservative, Centre-right): l very much respect the attitude of the Minister towards the project and this debate. Will he also mention to HS2 another concern of my constituents, which is that when they are suffering from great stress as a result of this project—we are talking about some fairly elderly folk—there is no particular provision for them at their local GP surgeries to receive some kind of additional counselling to help them overcome it?
Topical Questions — House of Commons, 2016-12-08
Topic: Health
Justine Greening (Conservative, Centre-right): The EHRC performs an important and valuable role, and its chair, David Isaac, and his board are well equipped for this task. The commission receives, and will continue to receive, sufficient funds to enable it to fulfil its full range of statutory duties.
Topical Questions — House of Commons, 2016-12-08
Topic: Health
Questions: Research from Guide Dogs has shown that 42% of surveyed assistance dog owners were refused carriage by a taxi driver in the past year, despite its being illegal. Ministers in the Department for Transport are showing great determination to address this wholly unacceptable discrimination, including through enforcement and education. What will the Minister’s Department do to support these efforts?; One of the changes to the state pension that everyone should welcome, but which is not as well known as it should be, is the recognition given to the years spent by women bringing up children, which now count as a national insurance credit towards a full state pension. Will my hon. Friend update the House on the number of women starting to benefit from this and its estimated value during a mother’s retirement?; According to Age UK, there is clear evidence that older people with cancer are too often under-treated, owing to judgments made on the basis of their age rather than their overall health and fitness. Age discrimination in the NHS is illegal under the Equality Act 2010, so will the Minister tell us what discussions she has had with colleagues in the Department of Health about a plan to improve cancer survival rates for people of all ages?
Caroline Fiona Ellen Nokes (Conservative, Centre-right): As the hon. Lady will know, the Department for Work and Pensions has recently published the work and health Green Paper, and we are looking at working very closely with the Department of Health on a whole range of issues to make sure that older people and our pensioners are treated fairly by all Government Departments and services.
Cancer Strategy — House of Commons, 2016-12-08
Topic: Health
Johanna Peta Churchill (Conservative, Centre-right): On that particular point about targeted interoperable radiotherapy, I too have spoken to these professors, and I understand where they are in the clearance process. I find it a little bit concerning when there is a lack of money in the system. Is my hon. Friend aware that there are half a dozen machines around the country that could deliver that targeted therapy? Perhaps we need to look at what we should do first—whether it is purchasing the machines or giving the clearance in full.
Cancer Strategy — House of Commons, 2016-12-08
Topic: Health
David Arthur Stephen Tredinnick (Conservative, Centre-right): My hon. Friend makes her point very well. In his excellent presentation, Simon Stevens talked about bringing new equipment onstream for radiography, I believe. [Interruption.] Yes, my hon. Friend was there, and she confirms this. I certainly agree with what she said, and we need to wake up to what is being invented in Britain and used across the world I shall conclude shortly, in case anyone else is hoping to catch your eye, Madam Deputy Speaker. I want to finish with a couple of other points. There are other treatments out there, to which people turn in desperation when they reach the end of their conventional treatments. One of them is called oxygen therapy, and broadly speaking it means getting more oxygen than is normally received, from a container. It is not a very expensive treatment, and the information I am getting is that it produces spectacular results when it comes to energising people and improving their sense of self-worth and wellbeing My final point is one that I find amazing. In the great cancer hospitals and clinics of this country, diet is seen as a sideline. In some of these institutions, the diet is, frankly, appalling, but I am not going to name of any of them this afternoon. Like most colleagues, I have a big enough postbag already and I do not want to hear the defence. Anyone attending a big clinic in America, such as the Mayo Clinic, can say goodbye to dairy and sugar, and hello to more juices. The Haven in Fulham certainly uses a lot of raw juices and raw vegetables. Diet is absolutely fundamental. When I worked in the computer industry, we used to say "Garbage in; garbage out"—and the same applies to humans. Our outputs as a being—[Interruption.] The hon. Member for Scunthorpe (Nic Dakin) does me the honour of laughing, but it is true. Diet is such a soft ball to hit, is it not? We are spending millions of pounds on all these expensive treatments, but what about telling people to cut back on sugar? Well, there we are I have tried to address some of the issues following the landmark speech at a landmark conference on Tuesday. For the first time, we have seen a lot of money set aside for developing aftercare for patients and improving services around mainstream medicine My hon. Friend the Minister has a great opportunity to make his mark in the House. His Department is, I believe, the fourth largest employer in the world. I think the Red Army comes top and McDonald’s second; I expect another burger provider comes third; and my hon. Friend is presiding over part of an organisation that comes fourth. His brief gives him enormous opportunities to improve the quality of life of cancer patients in this country, and by the time he has finished, there should not be just an increase in the cancer survival rate from 60% to70%—his target should be 80% Madam Deputy Speaker, I rest my case.
Cancer Strategy — House of Commons, 2016-12-08
Topic: Health
Robert John Blackman (Conservative, Centre-right): When the change in law came through, a number of people objected to it, saying that it would not be enforceable. I remember back to my childhood when both of my parents were smoking in the car in front of me. It was difficult then as a child to say, "Please, will you not smoke, because I do not like it?" It was just easier to open the window. I do not want children to go through that. It is right and important that we changed the law in that way, as we know that second-hand smoke is a key killer of young lungs. It was a significant development—and a development that people did not think would happen. People did not think that we could introduce this change and get it through both Chambers, but I am delighted to say that we did it and that it was the right thing to do.
Cancer Strategy — House of Commons, 2016-12-08
Topic: Health
Johanna Peta Churchill (Conservative, Centre-right): I thank my hon. Friend for providing such a powerful case. I could not agree with him more. To my way of thinking, banning smoking would do me, but we probably cannot go that far. Does he agree that the broader point of health economics is also important? Lung cancer is not the only issue. There is also emphysema, pulmonary disease and so on. If we sort out the tobacco issue, we could make much broader savings across the health service.
Cancer Strategy — House of Commons, 2016-12-08
Topic: Health
Henry Edward Millar Smith (Conservative, Centre-right): My hon. Friend is making the powerful point that if we reduce preventable cancers, we can redirect resources to the difficult cancers. It is a fact that more than 230,000 people in the United Kingdom suffer from blood cancers. As in the case of pancreatic cancer, which the hon. Member for Scunthorpe (Nic Dakin) mentioned, if we could better treat those difficult cancers with those resources, we could go so much further.
Cancer Strategy — House of Commons, 2016-12-08
Topic: Health
Robert John Blackman (Conservative, Centre-right): Clearly, the priority has to be to eliminate what we can eliminate. If people smoke, they put themselves at risk of cancer—as I said, 14 different cancers are affected by smoking. If people stop smoking, it eliminates that risk. Equally, through diet, people can eliminate some of the risks. However, there are cancers that are not affected by smoking or diet. Therefore, if we can reuse resources and concentrate on the detection or treatment of the more difficult cancers, the health of the nation must be improved. I bring my remarks to a close by saying that I hope we will get an answer in a few minutes to the question we are all asking: may we please have a date—with a day, a month and a year—when we will get the tobacco control plan?
Cancer Strategy — House of Commons, 2016-12-08
Topic: Health
Rebecca Elizabeth Scott Harris (Conservative, Centre-right): My mother-in-law passed away from secondary metastatic breast cancer after opportunities to diagnose her were missed. It has been brought to my attention that we do not keep very good records or data on metastasized breast cancer. The cancer pathway does not provide a specialist nurse for those with breast cancer, and we do not seem to provide a specialist nurse for those with metastasized breast cancer, either.
Cancer Strategy — House of Commons, 2016-12-08
Topic: Health
Johanna Peta Churchill (Conservative, Centre-right): I agree with my hon. Friend. People who are diagnosed with metastatic cancers—not only of the breast, but across the piece—feel like they are dropping through the cracks. They do not necessarily get a clinical nurse specialist, so that is another area for the specialist workforce to address. We need to make sure that we catch people on the journey, because it may be iterative. People may feel fit and well, but then find that they have to use the services again, so our approach needs to be flexible My hon. Friend has mentioned the importance of the ecosystem of research, hospitals and patients. My hon. Friend the Member for Crawley works hard with the Bloodwise charity, which is truly emblematic of an empowering organisation that works with the patient, clinician and researcher to help drive understanding. That is one way of giving UK plc a huge advantage. The hon. Member for Strangford has said that we need to look at the ecosystem, which is not just about cancer treatment at the end, but about researchers, universities, those brilliant students and staff whom we welcome from Europe and everyone in the pharmaceutical industry and charities working collaboratively to get the best outcome possible. That is how we will start to rise up the table and be as good as Sweden and other countries whose patients have truly fantastic outcomes Timely interventions can help recovery. I want to understand how recovery packages are being rolled out, because the issue of the workforce is critical The hon. Member for Bosworth (David Tredinnick) has mentioned alternative therapies, which can be useful, but this is a space in which charities can help people. Only this week, the Countryside Alliance Foundation took women who have received treatment fly-fishing. They find that the experience of being outside, doing something physical and enjoying nature gives them a huge sense of wellbeing. Personally, I do not think that it is a question of either/or; it is a question of joining them together Finally, I know that this is not the Minister’s area, but I would like him to take it back with him. I welcome the cancer drugs fund, but I am worried about those who benefit from combined treatments. Melanoma Focus has said that people on combined treatments may be disadvantaged, because not all of them will have access to the cancer drugs fund. I hope that the fund will be flexible and that the matter will be addressed.
Engagements — House of Commons, 2016-11-02
Topic: Health
Questions: I applaud the Government’s continued commitment to infrastructure development, with 6,000 projects in the pipeline worth £480 billion. Will the Government quickly and speedily take forward the lower Thames crossing and extra investment in Kent roads, which will help to provide more homes, jobs and businesses, and help people in Kent, Medway and the Thames Gateway area?; Northamptonshire has for a long time had a growing population without the right level of funding for our public services. Can my right hon. Friend assure me that the current reviews of the funding formulas for schools, policing and health will properly reflect the population growths in Northampton and the rest of the county so that our services get the funding they need?; Does the Prime Minister agree that it is disappointing that we did not hear from the Leader of the Opposition any welcome for the huge boost to manufacturing and employment that has come from Nissan’s decision to produce two new models at its factory? Does she agree that that decision demonstrates great confidence in the UK, with benefits throughout the supply chain, which includes companies such as Automotive Insulations in my constituency?; What assurances can the Prime Minister give to the agri-food sector right across the United Kingdom that it will be given the important status required in Brexit negotiations?; Last week’s announcement on the report on accelerated access to medicines will have a positive impact on the lives of children and adults with a rare genetic or undiagnosed condition. For decades, patients have struggled to get access to medicines in a timely fashion, and the work of my hon. Friend the Member for Mid Norfolk (George Freeman) made massive progress. Will the Prime Minister confirm that if the programme is successful with the first five to 10 drugs in the first year, it will be extended to further drugs in following years?
Theresa Mary May (Conservative, Centre-right): My hon. Friend is right to welcome the accelerated access review and to pay tribute to my hon. Friend the Member for Mid Norfolk (George Freeman), who has done so much to place life sciences in the UK on the agenda and to ensure that the UK develops as the best possible place to develop new drugs, which is exactly what we want to see. The Department of Health will look at the review’s recommendations and respond to them shortly. This is an important development in our ability to accelerate access to drugs, which is to the benefit of patients.
Community Pharmacies — House of Commons, 2016-11-02
Topic: Health
Alistair James Hendrie Burt (Conservative, Centre-right): It may be helpful if I make a brief intervention at this stage. I gave an estimate which was based on what we thought was a possible worst-case scenario. The Department never had any plans to close pharmacies. It was the best estimate that I had at the time, but it was not a definitive figure.
Community Pharmacies — House of Commons, 2016-11-02
Topic: Health
Robert Edward Jenrick (Conservative, Centre-right): Will the hon. Gentleman at least acknowledge that we all support community pharmacies? The town I live in has 3,500 residents and there are four pharmacies within a quarter of a mile. Will he at least acknowledge that a model that gives a block grant of £25,000 to each of those pharmacies purely for establishing themselves regardless of demand obviously needs review?
Community Pharmacies — House of Commons, 2016-11-02
Topic: Health
Andrew William Murrison (Conservative, Centre-right): Surely the hon. Gentleman accepts that we have to get the most efficiencies we possibly can from the system? His party colleague the right hon. Member for Doncaster Central (Dame Rosie Winterton) made a serious point about engaging with pharmacies to see how we can do it better. Does he agree—I would be interested to know why this is not in his motion—that category M clawbacks, which are levied exclusively on small independent pharmacies, might be extended to vertically integrated wholesalers as a way of making sure the system is more efficient than at present?
Community Pharmacies — House of Commons, 2016-11-02
Topic: Health
David Mowat (Conservative, Centre-right): I beg to move an amendment, to leave out from "NHS services" to the end of the Question and add: "welcomes the Government’s proposals to further integrate community pharmacy into the NHS, including through the Pharmacy Integration Fund, and make better use of pharmacists’ clinical expertise, including investing £112 million to deliver a further 1,500 pharmacists in general practice by 2020; supports the need to reform the funding system to ensure better value for the taxpayer; and welcomes the establishment of a Pharmacy Access Scheme which will ensure all patients in all parts of the country continue to enjoy good access to a local community pharmacy." I welcome the opportunity to set out again the Government’s approach to pharmacy in general and community pharmacy in particular over the next few years. I will also address some of the points that we just heard, which were, frankly, alarmist scare-mongering The proposals I announced two weeks ago are directed at four main areas: first, the need to better integrate pharmacy with GPs, primary care and the NHS more widely; secondly, the need for the existing community pharmacy network to move from a dispensing-based model to a value-added services-based model; thirdly, the need to continue to work with NHS England to ensure value for every penny we spend on the NHS; and fourthly, the need to ensure that, as we undertake these reforms, everybody in the country continues to have ready access to a community pharmacy First, on integration with the NHS, especially in general practice, over the weekend Simon Stevens, the NHS England chief executive, again reiterated the importance of that and why he supports this process. We know we need to expand the number of GPs, and by 2020 we will have a further 5,000 doctors working in this area, but as well as recruiting and retaining more doctors, we need to provide them with further support. The "General Practice Forward View", published by NHS England, has set out fully costed plans to recruit a further 1,500 clinical pharmacists into GP practices by 2020. By then there will be one pharmacist working within a GP practice for every 30,000 of population. Most of these will be prescribing pharmacists, and all will have a role in performing medicine reviews and leveraging GP time. This is a major investment and it is already happening.
Community Pharmacies — House of Commons, 2016-11-02
Topic: Health
Huw William Merriman (Conservative, Centre-right): The point I wanted to make when trying to intervene on the hon. Member for Leicester South (Jonathan Ashworth) was that I recently went to a pharmacy in my town of Bexhill, and it is making deliveries to every single customer who asks for a delivery, not just the vulnerable and the elderly. It does so because if it did not Lloyds would put it out of business. Does the Minister agree that that shows that there are efficiencies to be made, and the fact that those efficiencies are recycled in the health service has got to be good for all our constituents?
Community Pharmacies — House of Commons, 2016-11-02
Topic: Health
David Mowat (Conservative, Centre-right): Our view on the structure of the industry is that it is up to individual companies within the sector to organise themselves and to provide their services as efficiently as possible. It is true that 70% of all pharmacies are either chains, multiples or public companies, and I will address that point later.
Community Pharmacies — House of Commons, 2016-11-02
Topic: Health
David Mowat (Conservative, Centre-right): I want to make some progress Secondly, we want to see an enhanced role for the community pharmacy network in providing value-added services. This is an aspiration that we share with the network and its representatives. To that end, NHS England has commissioned Richard Murray of the King’s Fund to produce an evidence-based report to determine which types of primary care services are best done by pharmacists over the next two or three years. The report, which will be published later this year, will inform NHS England’s decisions on how to use the integration fund of £42 million that I announced two weeks ago. There are many candidate areas, including long-term conditions, minor ailments, better care home support and more medicine reviews, as well as the work that pharmacists do in public health.
Community Pharmacies — House of Commons, 2016-11-02
Topic: Health
David Mowat (Conservative, Centre-right): The impact review, which was published at the same time as my statement two weeks ago, estimated that the amount of extra time that people would have to spend going to a pharmacy would be a matter of seconds, even if we had, say, 100 closures. The impact review sets that out in some detail. Did someone sitting behind me wish to intervene?
Community Pharmacies — House of Commons, 2016-11-02
Topic: Health
Oliver Newton Colvile (Conservative, Centre-right): Thank you, Mr Speaker. I was just trying to find something that was going to inform my intervention. Is my hon. Friend the Minister aware that in Devon, about £5.5 million is wasted on unused medicines? We need to do something about that.